TSVT(Delisted)
2seventy bioยทNASDAQ
--
--(--)
TSVT Profile
2seventy Bio, Inc.
A leading immuno-oncology cell therapy company that develops gene,cell therapies and oncology roots for cancer and severe genetic diseases
60 Binney Street
, Cambridge
, Massachusetts 02142
--
2seventy bio, Inc., was incorporated in Delaware on April 26, 2021. The company is a cell and gene therapy company focused on the research, development and commercialization of cancer translational therapies. The company is advancing several preclinical and clinical programs in oncology and, together with their partner Bristol-Myers Squibb (Bristol-Myers Squibb), is providing Abecma, including immunomodulators, proteasome inhibitors and anti-CD38 monoclonal antibodies, to multiple myeloma patients in the United States after approval for at least four prior treatments.
